Medtech fundings in August 2014

Fundings in medical technology for the month of August 2014 totaled a tepid $199 million, the largest of which are the $55 million funding of Civitas Therapeutics and the $30 million funding of OptiNose. Below were the top fundings for the month.

Company, funding Product/technology
Civitas Therapeutics, inc. has raised $55.25 million in a round of funding according to a regulatory filing Respiratory drug delivery
OptiNose, Inc., has raised $30 million of a planned $35 million round of funding according to a regulatory filing Powered intranasal drug delivery
Claret Medical, Inc., has raised up to $18 million in a Series B round of funding according to press reports Catheter for cerebral protection during transcatheter aortic valve implantation
Silk Road Medical, Inc., has raised $15 million of a planned $22.5 million round of funding according to a regulatory filing Transcarotid stent for treatment of neurovascular disorders
ViaCyte, Inc., has raised $15 million in a round of funding according to a regulatory filing Cell therapy-based artificial pancreas for diabetes
Seventh Sense Biosystems, Inc., has raised $10.47 million of a planned $16.47 million round of funding according to a regulatory filing Phlebotomy technologies

For the complete list of medtech fundings in August 2014, see link. For a historical list of the fundings in medtech, by month, since 2009, see link.

Leave a Reply